France· FR:68296666
DOPRAM 2 POUR CENT, solution injectable
A doxapram product containing chlorhydrate de doxapram, registered in France by EFISCIENS (MALTE). The same ATC class is registered in 9 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Doxapram is registered in 9 of 19 countries.
Countries holding a registration under ATC R07AB01 (doxapram), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 5 of them publish a price we can compare per daily dose
Doxapram · ATC R07AB01
9 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE DOXAPRAM
- Manufacturer
- EFISCIENS (MALTE)
- Country
- France (FR)
- ATC code
- R07AB01
- ATC class
- Doxapram
- Defined daily dose
- 0.4 g, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip13340095509524850 ampoule(s) en verre de 3 ml
- cip1334009560717841 flacon(s) en verre de 20 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
66 interactions on record for doxapram.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doxapram · interactions on record
66 records
- 20 severe
- 46 moderate
Most severe, free to view
- LinezolidJ01XX08severe
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doxapram in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDopram 100mg/5ml solution for injection ampoulesMercury Pharma Group Ltd
- FinlandDopramMeda Oy
- IrelandDoxapram Hydrochloride 20mg/ml Solution for InjectionMercuryPharm Ltd
- United StatesDopramHikma Pharmaceuticals USA Inc.
- GermanyDopramCarinopharm Gmbh
- BelgiumDopram 20 mg/mlEumedica Pharmaceuticals
- NorwayDopramCarinopharm
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Dopram
- Germany · Dopram
- United Kingdom (Northern Ireland) · Dopram, Doxapram Hydrochloride Mercury Pharmaceuticals Limited
- Ireland · Doxapram Hydrochloride Mercurypharm Ltd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2387df74-e01a-49a1-b0ed-1aea59e3f050 GET /v1/drugs/2387df74-e01a-49a1-b0ed-1aea59e3f050?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68296666",
"date_amm": "1997-12-08",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE DOXAPRAM",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about doxapram.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.